Contact: Xochilt Maher
4501 Colorado Blvd
6 articles with Shire Plc
Shire launches screen responsibly, an eyelove® initiative dedicated to prioritizing eye health in a screen-saturated world
Shire plc (LSE: SHP, NASDAQ: SHPG) announced the launch of screen responsibly, its new educational initiative about the intersection between our screen use and eye health.
coreHEM Publishes Core Outcome Set for Hemophilia Clinical Trials; Prepares to Launch Next Phase of Work
The coreHEM initiative has announced the publication of a core outcome set for clinical trials of gene therapy in hemophilia.
LCS Group Sues Pharma Giant Shire for Breach of Contract & Fraud in Patent Dispute, Potential Damages “Into the Billions”
LCS Group, LLC (“LCS”) announced today that it has filed a federal lawsuit in the Southern District of New York against Shire Plc, Shire Development LLC, and Shire LLC (“Shire”) alleging Shire breached its contract with LCS and interfered with LCS’s prospective economic advantage, as well as perpetrated fraud [active case number for the complaint is 1:18-cv-02688-AT].
Notification of transactions by person discharging managerial responsibilities.
Shire reports 8% pro forma product sales and strong earnings growth resulting in record operating cash flow for full year 2017.
Shire is preparing to conduct Phase 3 trials investigating SHP647 for the treatment of moderately to severely active Crohn's disease in adults